Global Director, Regulatory Affairs – Advertising & Promotion

Regeneron Pharmaceuticals, Inc.; United States; Hybride; USD 205 000 - 342 000; Plein temps

Résumé du poste

Regeneron Pharmaceuticals, Inc. in the United States seeks a Director, Regulatory Affairs Advertising & Promotion Global to lead regulatory strategy for advertising and promotion across US and global markets, shaping product messaging and ensuring compliant commercialization.

You will collaborate with Marketing, Medical Affairs, Legal and Regulatory teams, oversee FDA promotional interactions, and drive policy standardization in a hybrid remote model.

Qualifications

• Master's, PharmD or PhD; or Bachelor's in Life Sciences.
• Minimum 7 years in biotechnology/pharmaceutical industry.
• Deep expertise in advertising and promotion regulations and precedents.
• Experience with FDA OPDP/APLB and product launches.
• Global promotional review and labeling regulations experience preferred.

Responsabilités

• Lead US and global regulatory activities for advertising and promotion.
• Advise on product messaging and promotional materials.
• Provide regulatory guidance for conferences, disease awareness, and speaker programs.
• Review promotional communications for compliance with applicable requirements.
• Partner with Marketing, Medical Affairs, Legal, and Regulatory leads.
• Oversee FDA promotional interactions and Form 2253 compliance.
• Drive process improvements and policy standardization.

Connaissances

Regulatory strategy

Cross-functional leadership

FDA experience

Promotion regulations

Communication skills

Formation

Master's/PhD/PharmD

Life Sciences degree

Description du poste

Regeneron Pharmaceuticals, Inc. in the United States seeks a Director, Regulatory Affairs Advertising & Promotion Global to lead regulatory strategy for advertising and promotion across US and global markets, shaping product messaging and ensuring compliant commercialization.

You will collaborate with Marketing, Medical Affairs, Legal and Regulatory teams, oversee FDA promotional interactions, and drive policy standardization in a hybrid remote model.